To treat or not to treat Helicobacter pylori to benefit asthma patients

Expert Review of Respiratory Medicine

Volumn 4, Issue 2, 2010, Pages 147-150

  Delios, Mario M ^a   Bernard, Marina De ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HELICOBACTER PYLORI DERIVED NEUTROPHIL ACTIVATING PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; RISK FACTOR; STOMACH CANCER; STOMACH LYMPHOMA; TH1 CELL; TH2 CELL;

EID: 77951454438     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.9     Document Type: Editorial

References (23)

1. Warren JR, Marshall BJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcer ulceration. Lancet i, 1273-1275 (1983).
2. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577 (1993).
3. D'Elios MM, Appelmelk BJ, Amedei A et al. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 7, 316-323 (2004).
4. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 1-241 (1994).
5. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119, 2475-2487 (2009).
6. D'Elios MM, Manghetti M, De Carli M et al. Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158, 962-967 (1997).
7. D'Elios MM, Amedei A, Benagiano M et al. Helicobacter pylori, T cells and cytokines: the "dangerous liaisons". FEMS Immunol. Med. Mic. 44, 113-119 (2005).
8. Fox JG, Beck P, Dangler CA et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 5, 536-542 (2000).
9. D'Elios MM, Manghetti M, De Carli M et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27, 1751-1755 (1997).
10. Amedei A, Cappon A, Codolo G et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116, 1092-1101 (2006).
11. Chatila TA, Li N, Garcia-Lloret et al. T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J. Allergy Clin. Immunol. 121, 812-823 (2008).
12. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 295-304 (1992).
13. Del Prete G, De Carli M, D'Elios MM et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23, 1445-1449 (1993).
14. Kon OM, Kay AB. T cells and chronic asthma. Int. Arch. Allergy Immunol. 118, 2-4 (1999).
15. Betts RJ, Kemeny DM. CD8+ T cells in asthma: friend or foe? Pharmacol. Ther. 121, 155-168 (2009).
16. Strachan DP. Hay fever, hygiene and household size. BMJ 299, 1259-1260 (1989).
17. Herz U, Lacy P, Renz H et al. The influence of infections on the development and severity of allergic disorders. Curr. Opin. Immunol. 12, 632-640 (2000).
18. Wohlleben G, Erb KJ. Immune stimulatory strategies for the prevention and treatment of asthma. Curr. Pharm. Des. 12, 3281-3292 (2006).
19. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 167, 821-827 (2007).
20. Hirota K, Kazaoka K, Niimoto I et al. Discovery of 8-hydroxyadenines as a novel type of interferon inducer. J. Med. Chem. 45, 5419-5422 (2002).
21. Trujillo-Vargas CM, Mayer KD, Bickert T et al. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Clin. Exp. Allergy 35, 1003-1013 (2005).
22. Codolo G, Mazzi P, Amedei A et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell. Microbiol. 10, 2355-2363 (2008).
23. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56, 772-781 (2007). (Pubitemid 46854190)